Arphra/Issuer/WAT

WAT

Waters Corporation

HealthcareMedical - Diagnostics & ResearchUSUSD

$383.57

-1.06%Live · FMPMay 29, 2026

AI Brief

Market cap

$25B

52w range

275.05 – 414.15

P / E

—

EPS

—

Volume

1.44M

Revenue · FY

$3.17B

+6.99% YoY

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

$1.78M

4 txns

Sold

$4.88M

6 txns

Net flow

−$3.09M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$301.38

Change

-12.31%

Period high

$412.54

Period low

$277.72

Period start

$343.682025-06-02

Through 2026-05-04

Peers

Price change · trailing returns

Live · FMP

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+4.61%	+13.43%	+24.04%	+20.10%	-4.92%	+0.98%	+11.61%	+52.68%	+20.43%	+178.86%	+10044.00%

Aftermarket

Live · FMP

May 29, 10:48 PM

Last trade

$383.75

279 sh

Bid

$359.00

3 sh

Ask

$383.75

1 sh

Spread

$24.750

Fair value

Football field →

Weighted blend

$357.52

-6.79% vs spot

Recommendation

Underweight

15 of 16 methods

Method spread

3bull11bear

±5% threshold

Analyst PT consensus: $402.57 (+4.95%)

Total assets

$5.08B

Total debt

$1.41B

Cash & equiv

$587.83M

Operating CF

$652.56M

Free cash flow

$539.81M

Buybacks

-$14.67M

Analyst view

DB · price_targets + analyst_grades

Consensus target

$402.57

+4.95% upside

Low

$350.00

Median

$400.00

High

$480.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

No recent news for WAT.

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q4 Dec 2025	$932.36M	$225.21M	$3.77
Q3 Sep 2025	$799.89M	$148.92M	$2.50
Q2 Jun 2025	$771.33M	$147.11M	$2.47
Q1 Mar 2025	$661.71M	$121.38M	$2.03
Q4 Dec 2024	$872.71M	$231.4M	$3.88
Q3 Sep 2024	$740.31M	$161.5M	$2.71

Recent insiders

All →

Insider	Action	Shares	Value	Date
Jiang Wei director	Buy	500	$144.73K	Mar 16, 2026
FEARON RICHARD H director	Buy	1,000	$306.34K	Mar 06, 2026
FEARON RICHARD H director	Buy	1,000	$332.9K	May 28, 2024
KUEBLER CHRISTOPHER A director	Sell	4,000	$1.45M	May 15, 2024
BADDOUR LINDA director	Sell	500	$177.77K	Mar 13, 2024
KUEBLER CHRISTOPHER A director	Sell	4,000	$1.17M	Aug 04, 2023

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$3.17B	$893.22M	$642.63M	$10.76	+20.30%
FY 2024	$2.96B	$826.35M	$637.83M	$10.71	+21.56%
FY 2023	$2.96B	$817.68M	$642.23M	$10.84	+21.72%
FY 2022	$2.97B	$873.4M	$707.76M	$11.73	+23.81%
FY 2021	$2.79B	$821.71M	$692.84M	$11.17	+24.87%